Global call for innovative veterinary solutions for antimicrobial resistance (AMR) in ruminants and aquaculture
DHSC’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) and Canada’s International Development Research Centre (IDRC) are continuing their joint work through InnoVet-AMR to launch a global call for innovative veterinary solutions for antimicrobial resistance (AMR) in ruminants and aquaculture.
This work builds on GAMRIF and IDRC’s successful partnership through InnoVet-AMR 1.0. Details of InnoVet-AMR 1.0 can be found here.
InnoVet-AMR 2.0 is a 4-year, CA$26.3 million jointly funded partnership. The initiative is aimed at reducing the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security with a focus on low and middle income countries (LMICs).
The two main objectives are:
- Support research that will identify and develop prophylactic and therapeutic innovative veterinary solutions, including vaccines, to improve health, while reducing the use of antimicrobials in ruminants and aquaculture operations in LMICs;
- Build effective gender balanced partnerships to better contribute to discovery and development of innovative veterinary solutions to reduce the use of antimicrobials in ruminants and aquaculture operations in LMICs.
This is a global call for Research Proposals titled Innovative Veterinary Solutions for Antimicrobial Resistance (InnoVet-AMR) 2 in Food-Producing animals: Ruminants and Aquaculture.
The call invites research proposals focused on veterinary solutions, where new product-oriented solutions would significantly reduce the therapeutic and/or non-therapeutic use of antimicrobials in LMICs in ruminants and/or aquaculture production. These solutions should target the prevention and control of bacterial infectious diseases of importance in LMICs and the reduction of the use of antimicrobials while considering gender equity and inclusion and demonstrating commitment to climate change mitigation.
The deadline for applications is Monday 30th October 2023. Please see further details and apply via this link in English and note that it is also available in French and Spanish.
Apply for funding to advance the mechanistic understanding of host-pathogen interactions in farmed animals or to tackle veterinary antimicrobial resistance (Vet-AMR) or both.
You must be based at a UK research organisation eligible for BBSRC funding and you must have a partner in India eligible for DBT funding.
Projects will be made up of a UK component and an India component.
BBSRC will fund up to £1 million at 80% of the full economic cost to support the UK component and DBT will fund the India component. Total funding available is £5 million from BBSRC for the UK applicants with matched equivalent resources from DBT for successful Indian applicants.
Projects will have a duration of up to three years.
Apply for funding through a China UK Flagship Challenge funding opportunity to support China-UK research teams in the field of One Health research for epidemic preparedness and antimicrobial resistance (AMR).
Looking for internationally competitive, full-scale collaborative and innovative partnerships.
Collaborative research teams from China and the UK must submit parallel applications to MRC on behalf of UK Research and Innovation (UKRI) and MoST detailing a joint research programme across the two countries.
You will be responsible for developing your own collaborations.
You must be eligible to apply to your respective funder.
MRC and MoST will provide matched funding for up to three years.
Innovative nuclear and related molecular approaches for detection and characterization of antimicrobial resistance in animal production environment
FAO and IAEA are pleased to inform you that the call for proposals for the coordinated research project (CRP) on “Innovative Nuclear and Related Molecular Approaches for Detection and Characterization of Antimicrobial Resistance in Animal Production Environment” is now online.
The details of the call are available at the following link:
The last date for submission of proposals is 09 April 2023. See some additional information related to the CRP: FAO_IAEA_CRPD32043_AMR_
The ISIDORe Preparedness programme is now ready and that the new calls for proposals are open to applications for free of charge access to the consortium facilities and services!
To prevent future pandemics, and advance the development of the appropriate medical countermeasures, the ISIDORe preparedness programme includes a list of priority preparedness pathogens clustered in four calls for proposals to support research on the epidemic-prone pathogens such as Risk-Group 4 pathogens (Ebola virus, Marburg virus, Nipah virus, Hendra virus, Lassa virus, “New world arenaviruses”, CCHF virus); Respiratory Pathogens (zoonotic betacoronaviruses, Influenza A, Y. Pestis, M. Tuberculosis/bovis, C. burnetii ); Vector-borne Pathogens (Rift valley fever virus, Zika virus, Chikungunya virus, West Nile virus, Dengue virus, Japanese encephalitis virus, Yellow fever virus, Tick-borne encephalitis virus, Plasmodium, B. burgdorferi, Leishmania); and other pathogens with epidemic potential (pathogen X, Orthopoxviruses, Non polio enteroviruses, Polio enteroviruses).
The ISIDORe coordination team is also pleased to invite you to the Information Webinar dedicated to the Preparedness calls for proposals (RG4 pathogens, Respiratory pathogens, Vector-borne pathogens, Pathogen X) launched in November 2022. It aims to provide you with information about the calls and application modalities, as well as to answer your questions.
ISIDORe (Integrated Services for Infectious Disease Outbreak Research) Call Dedicated To SARS-CoV-2 and COVID-19
The ISIDORe consortium has announced the launch of its first call for proposals to support scientists with an interest in SARS-CoV-2 and COVID-19. The application is open as long as funding remains available
The research must be focused on one of the topics listed below.
SECTION 1: SURVEILLANCE & EPIDEMIC RISK MANAGEMENT
SECTION 2: UNDERSTANDING SARS-COV-2 & COVID-19
SECTION 3: DIAGNOSTICS
SECTION 4: THERAPEUTICS
SECTION 5: VACCINES
SECTION 6: SOCIAL SCIENCES & EPIDEMIOLOGY
To apply: submit proposals that will be evaluated based on their feasibility and scientific merit (independent peer review).
1. Browse our catalogue and identify the service that you need
2. Fill out the pre-application form visible at the bottom of each service catalogue section pages and hit the ‘SUBMIT’ button
3. After receiving an email with your ISIDORe ID number, follow the instructions to complete your application
Before you navigate our catalogue, please remember that for a pre-application submission:
You will need an ORCID number. If you don’t already have one, please go to orcid.org to obtain your own in a few clicks.
For multi-services requests, we’ll be happy to help: please contact us
PROCINORTE is now supporting research collaboration efforts between international government scientists (lead applicants) with a specific emphasis on priority research projects of mutual interest in both African Swine Fever (ASF) and Classical Swine Fever (CSF). The call will optimize the collaboration and knowledge sharing to protect animal health and enhance members’ collective capabilities.
This year, the 2022 PROCINORTE grant applications will be accepted for:
(1) International Scientific Training and Exchanges, up to US$25,000, to be considered and granted for up to 4 weeks and must occur in the current calendar year;
(2) Research Collaborations, up to US$50,000, which can cover 2 calendar years though must be completed by the end of 2023.
Please note funds cannot be provided to USDA scientists, nor the private sector, though US government scientists may be the lead applicant. Responses will depend on the number of applications received and the quality of the applications.
“Tackling diseases and reducing disease burden”. Tackling diseases (Single Stage – 2022) (HORIZON-HLTH-2022-DISEASE-07)
Call: Funding & tenders (europa.eu): “Tackling diseases and reducing disease burden”. Tackling diseases (Single Stage – 2022) (HORIZON-HLTH-2022-DISEASE-07)
The call, though not specific for animal health, includes the One health approach to preparedness for the next pandemic. Proposals under this topic should aim for delivering results that are directed towards and contributing to some of the following expected outcomes, including:
The scientific community has better understanding of the biology of the pathogens (virus, bacteria etc.), its transmission, its interaction with humans, animals and plants, in particular in view of emerging threats to human health, such as infectious diseases and anti-microbial resistance (AMR).
The call opened on 12 January 2022 and closes 21 April 2022 (17.00 CET)
The biennial Plowright Prize, which recognises an individual who has made significant contributions to the field of infectious diseases in animals, is officially opened.
Walter Plowright was widely regarded as one of the world’s most eminent veterinary virologists and authorities on rinderpest, whose development of a tissue culture vaccine represented a key milestone in efforts to control it.
The prize recipient will receive £75,000, to be used to support research or other improvement activity that contributes to the control, management and eradication of infectious diseases in animals. For these purposes, the term ‘animal’ includes both domestic and free-living species – mammals, birds or fish.
This prize recognises an individual whose work has had a significant impact on the control, management and eradication of infectious diseases of animals. Their contribution will demonstrate animal, humanitarian or economic benefit.
The prize is open to any veterinary surgeon, veterinary nurse or research scientist working in Europe or the Commonwealth. The nominee may be working in practice, academia, a research institute/organisation, industry, government or another relevant sector. Institutions and/or organisations are not eligible to receive the prize.
For further information see: https://knowledge.rcvs.org.uk/grants/available-grants/the-plowright-prize-2021/